(Date:7/25/2008)...e American Society for Gastrointestinal Endoscopy ...opy in the bariatric surgery patient. The rising p...success in surgical interventions led to a marked ...rformed in the U.S., from 13,365 in 1998 to 102,79... preoperative patient and the postoperative patien...
(Date:7/25/2008)...ent of Defense and Federal Agencies in, the execu... Phoenix is a, four-day, multi-agency collaborat...ate and local agencies with large and complex inci...a vital, ad-hoc, secure mobile communications in... NORFOLK, Va., July 25 /PRNewswire/ -- Dataline L...
(Date:7/25/2008)...The Elekta Family of Companies will,showcase their...2008,American Association of Physicists in Medicin...nt forces of Elekta, IMPAC and CMS are delivering,...ry solutions that,streamline the treatment process...ll as enhance clinician efficiency., "Our recent ...
(Date:7/25/2008)... delivers immediate cost savings for http://www.l... language interpreters] to firms switching langua... Washington, D.C. (Vocus)....com/index.html [(Language Learning Enterprises, ...slation, and language instruction services to thou...
Breaking Medicine News(10 mins):Health News:ASGE issues guidelines on the role of endoscopy in the bariatric surgery patient 2Health News:ASGE issues guidelines on the role of endoscopy in the bariatric surgery patient 3Health News:Dataline Announces Participation in Operation Golden Phoenix 2Health News:Dataline Announces Participation in Operation Golden Phoenix 3Health News:Elekta Family of Companies to Highlight Cancer Treatment Solutions at 2008 AAPM Annual Meeting 2Health News:Elekta Family of Companies to Highlight Cancer Treatment Solutions at 2008 AAPM Annual Meeting 3Health News:LLE Launches Over-the-Phone Interpretation OPI Easy Switch Program 2Health News:LLE Launches Over-the-Phone Interpretation OPI Easy Switch Program 3...sity of Texas, have shown that use of oral contrac...r.Up to 70 per cent of US women born since 1950 ha...earch has suggested that use of the hormones in th...hile other studies have failed to reveal a connect...
... that three years on, a group of kidney cancer pat...nks to a new procedure. Researchers at the Univers...for kidney cancer, called interventional-MRI renal...resonance imaging to guide a surgical probe while ...
... drugs used to treat hypertension could delay musc...er, research associate at University of Hopkins ha...n Converting Enzyme) ACE-inhibitor //drugs, which ...cts on muscle strength and overall physical perfor...
...New York, there has been a declining trend in mort...ncy has increased. Researchers at the University o... the deadliest form of skin cancer, between 1981 a...t increase in cases among men - from 2.0 cases per...
Other Medicine News:Health News:Hypertension drugs could lower Disability 2(Date:7/23/2008)... ASPS Study Finds Some Areas of the Body Have ...EIGHTS, Ill., July 23 /PRNewswire-USNewswire/ -- F...through liposuction was found to be,an excellent s...rations,than other areas of the body, reports a Br...tructive Surgery(R), the official medical journal ...
(Date:7/23/2008)... SEATTLE, July 23 /- De...d that it expects the Independent Data,Monitoring ...erim analysis,of overall survival relating to the ...te AdenoCarcinoma Treatment, also known as D9902B)...VENGE is the Company,s investigational,active cell...
(Date:7/22/2008)... BRISBANE, Australia, July 22 /PRNewswire-Firs...ed late yesterday, the Board of Progen,Pharmaceuti...ced that it,had discontinued the PI-88 phase 3 stu... direction to develop its existing portfolio of co...ire additional compounds and,opportunities through...
(Date:7/22/2008)... MINNEAPOLIS, July 22 /- Nonin Me...ring solutions for more than 20 years, has entered...technology to measure,regional oxygen saturation. ...y is the continuous monitoring of the regional blo... Early testing data and outcomes from an ongoing ...
Breaking Medicine Technology:Want a Reason to Love Your Lower Belly Fat? It's Rich in Stem Cells 2Dendreon Expects Interim Data Analysis for Phase 3 PROVENGE IMPACT Trial in October 2Dendreon Expects Interim Data Analysis for Phase 3 PROVENGE IMPACT Trial in October 3Dendreon Expects Interim Data Analysis for Phase 3 PROVENGE IMPACT Trial in October 4Progen Terminates PATHWAY Trial & Confirms Focus on Potential High Value Molecules and M&A 2Progen Terminates PATHWAY Trial & Confirms Focus on Potential High Value Molecules and M&A 3Nonin Medical Inc. Announces Entry Into the Cerebral Oximeter Market 2CafePress Supports Stand Up To Cancer With Online Store to Help Raise Awareness and Funds for Research 22059 1CafePress Supports Stand Up To Cancer With Online Store to Help Raise Awareness and Funds for Research 22059 2Faith Haines Kolb Joins PROMETRIKA as Senior Director of Clinical Operations and Data Management 6052 1Faith Haines Kolb Joins PROMETRIKA as Senior Director of Clinical Operations and Data Management 6052 2Faith Haines Kolb Joins PROMETRIKA as Senior Director of Clinical Operations and Data Management 6052 3First successful reverse vasectomy on endangered species performed at the National Zoo 3662 1First successful reverse vasectomy on endangered species performed at the National Zoo 3662 2First successful reverse vasectomy on endangered species performed at the National Zoo 3662 3Wavelets crunch through doctors day long struggle to diagnose brain tumors 22053 1Wavelets crunch through doctors day long struggle to diagnose brain tumors 22053 2... Tolerance Support Development,of Omega DUROS Cont...2, 2007 /PRNewswire/ -- Intarcia,Therapeutics, Inc...ay announced final results from a Phase 2 study of...atment-naive patients,with genotype 1 chronic hepa...eron in combination with ribavirin is well tolerat...
...11, 2007 (PRIME NEWSWIRE) --,Hana Biosciences (Nas...advancing cancer care, will present preclinical da...the American Association,for Cancer Research 100th...California. , Abstract No. 2210: "Combining talotr...ll lung cancer (NSCLC) athymic nude,mice xenograft...
Other Medicine Technology:Intarcia Therapeutics Announces Final Results From a Phase 2 Study,of Injectable Omega Interferon plus Ribavirin for the Treatment of,Hepatitis C Genotype-1 2Intarcia Therapeutics Announces Final Results From a Phase 2 Study,of Injectable Omega Interferon plus Ribavirin for the Treatment of,Hepatitis C Genotype-1 3Intarcia Therapeutics Announces Final Results From a Phase 2 Study,of Injectable Omega Interferon plus Ribavirin for the Treatment of,Hepatitis C Genotype-1 4Hana Biosciences Announces Data to be Presented On Talvesta,(Talotrexin) for Injection at The American Association for Cancer,Research Annual Meeting 2Hana Biosciences Announces Data to be Presented On Talvesta,(Talotrexin) for Injection at The American Association for Cancer,Research Annual Meeting 3...is a national reference laboratory and a worldwide...lopment. ARUP offers an extensive test menu of hig...nd anatomic pathology. Owned by the University of ... half of the nation's university teaching hospital...
...is a national reference laboratory and a worldwide...lopment. ARUP offers an extensive test menu of hig...nd anatomic pathology. Owned by the University of ... half of the nation's university teaching hospital...
...is a national reference laboratory and a worldwide...lopment. ARUP offers an extensive test menu of hig...nd anatomic pathology. Owned by the University of ... half of the nation's university teaching hospital...
...is a national reference laboratory and a worldwide...lopment. ARUP offers an extensive test menu of hig...nd anatomic pathology. Owned by the University of ... half of the nation's university teaching hospital...
Medicine Products: